日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction: Collagen-mediated pro-tumorigenic MAPK activation drives stromal-immune reprogramming in solid cancers

更正:胶原蛋白介导的促肿瘤 MAPK 激活驱动实体瘤中的基质免疫重编程

Ding, Junli; Lin, Hongxin; Fan, Hanfang; Xu, Liangfeng; Zhou, Haihua; Jiang, Huning; Wang, Zeyu; Xia, Tiansong; Cai, Yun; Zhu, Yichao; Xu, Junying

Collagen-mediated pro-tumorigenic MAPK activation drives stromal-immune reprogramming in solid cancers.

胶原蛋白介导的促肿瘤 MAPK 激活驱动实体瘤中的基质免疫重编程。

Ding Junli, Lin Hongxin, Fan Hanfang, Xu Liangfeng, Zhou Haihua, Jiang Huning, Wang Zeyu, Xia Tiansong, Cai Yun, Zhu Yichao, Xu Junying

Machine learning for predicting high axillary nodal burden in breast cancer patients with positive sentinel lymph nodes

利用机器学习预测前哨淋巴结阳性乳腺癌患者腋窝淋巴结负荷高低

Li, ShuaiKang; Yu, Xingying; Lin, Hongxin; Jin, Yufan; Xia, Tiansong

Polycystin-1 Mutant Alters Mechanotransduction in Response to Collagen and Extracellular Matrix Stiffness via Daam1-Dependent Microfilament Remodeling.

多囊蛋白-1突变体通过Daam1依赖的微丝重塑改变胶原蛋白和细胞外基质刚度的机械转导。

Zhou Jiaofeng, Deng Yibing, Mei Jie, Wan Mengyun, Xue Ningyi, Zong Xinyu, Zhou Ji, Ding Junli, Yan Ting, Jiang Yu, Xia Tiansong, Zheng Peng, Zhu Yichao

De-escalated neoadjuvant nab-paclitaxel combined with pyrotinib and trastuzumab in intrinsic HER2-enriched breast cancer (NJMU-BC01): a multicenter, single-arm, phase 2 trial

在HER2富集型乳腺癌中,新辅助化疗方案降低剂量,联合吡咯替尼和曲妥珠单抗治疗(NJMU-BC01):一项多中心、单臂II期临床试验

Pan, Hong; Ren, Yi; Zha, Mengyao; Liu, Mingduo; Liu, Xiaoan; Xie, Hui; Zha, Xiaoming; Zhao, Yi; Chen, Lin; Xia, Tiansong; Liu, Zhao; Tao, Jing; Pan, Hua; Sun, Yue; Li, Wei; Wang, Cong; Ding, Qiang; Wang, Shui; Zhou, Wenbin

Cancer stem cell specificity as new targets in breast tumor treatment

癌症干细胞特异性作为乳腺肿瘤治疗的新靶点

Zhang, Zhizheng; Li, Tao; Li, Yuan; Wang, X I; Liu, Hao; Shen, Xinyu; Xu, Ann; Xia, Tiansong; Xu, B O

Tumor-stroma proportion is associated with increased M2 macrophage abundance and predicts the resistance to immune checkpoint blockade in breast cancer.

肿瘤基质比例与 M2 巨噬细胞丰度增加相关,并可预测乳腺癌对免疫检查点阻断的耐药性

Liu Yincheng, Xue Ningyi, Liu Yuelin, Mei Jie, Cai Yun, Wang Zhenghui, Lin Hongxin, Wan Mengyun, Zhou Ji, Xia Tiansong, Zhu Yichao, Wang Shui

Aneuploid Circulating Endothelial Cells with Prognostic Value in Locally Advanced Breast Cancer Patients After Neoadjuvant Chemotherapy

新辅助化疗后局部晚期乳腺癌患者循环内皮细胞的非整倍体预后价值

Li, Minghui; Liu, Yuelin; Han, Xu; Li, Tao; Zhang, Zhizheng; Xue, Ningyi; Liang, Mengdi; Ma, Ge; Xia, Tiansong

An inflammatory-related genes signature based model for prognosis prediction in breast cancer

基于炎症相关基因特征的乳腺癌预后预测模型

Fu, Jingyue; Chen, Rui; Zhang, Zhizheng; Zhao, Jianyi; Xia, Tiansong

Value of negatively correlated miR-205-5p/HMGB3 and miR-96-5p/FOXO1 on the diagnosis of breast cancer and benign breast diseases

miR-205-5p/HMGB3 和 miR-96-5p/FOXO1 负相关性在乳腺癌和良性乳腺疾病诊断中的价值

Li, Jiaying; Peng, Shuang; Zou, Xuan; Geng, Xiangnan; Wang, Tongshan; Zhu, Wei; Xia, Tiansong